Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 69
Filter
1.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 561-571, 2018.
Article in English | WPRIM | ID: wpr-812374

ABSTRACT

Multidrug resistance (MDR) in human cancer is one of greatest challenges in cancer therapy. Natural products, especially the alkaloids, exert reversed effects on MDR with low toxicity, by interacting with various targets. In this review article, we summarize the recent progress made in the research of the main alkaloids, including classification, function, mechanism, research status, and application in reversing MDR.


Subject(s)
Animals , Humans , Alkaloids , Chemistry , Biological Products , Chemistry , Drug Antagonism , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Neoplasms , Drug Therapy
2.
Chinese Journal of Natural Medicines (English Ed.) ; (6): 561-571, 2018.
Article in English | WPRIM | ID: wpr-773585

ABSTRACT

Multidrug resistance (MDR) in human cancer is one of greatest challenges in cancer therapy. Natural products, especially the alkaloids, exert reversed effects on MDR with low toxicity, by interacting with various targets. In this review article, we summarize the recent progress made in the research of the main alkaloids, including classification, function, mechanism, research status, and application in reversing MDR.


Subject(s)
Animals , Humans , Alkaloids , Chemistry , Biological Products , Chemistry , Drug Antagonism , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Neoplasms , Drug Therapy
3.
Rev. ADM ; 73(5): 227-234, sept.-oct. 2016. tab
Article in Spanish | LILACS | ID: biblio-835299

ABSTRACT

Los antibióticos betalactámicos son los que más se usan en el tratamientoy profilaxis de las infecciones odontogénicas. Con frecuenciaes necesario prescribir un segundo antibiótico que incremente el efectodel primero. Debido a ello se hizo una revisión de los antibióticos y otros medicamentos que administrados simultáneamente o en forma secuencial con betalactámicos producen efectos deseados (sinergismo, potenciación) o indeseados (antagonismo) o provocan efectos adversos en el organismo.


Beta-lactams are the most commonly used antibiotics in the treatmentand prophylaxis of odontogenic infections. It is often necessary toprescribe a second antibiotic to increase the eff ect of the fi rst. For thisreason, we performed a review of antibiotics and other medicationswhich, when administered simultaneously or sequentially with betalactams,produce desirable (synergism, potentiation) or undesirable(antagonism) eff ects or provoke adverse eff ects in the organism.


Subject(s)
Humans , beta-Lactams/administration & dosage , beta-Lactams/pharmacokinetics , beta-Lactams/pharmacology , Drug Interactions , beta-Lactams/adverse effects , Cephalosporins/pharmacology , Drug Antagonism , Drug Synergism , Food-Drug Interactions
4.
China Journal of Chinese Materia Medica ; (24): 3630-3635, 2015.
Article in Chinese | WPRIM | ID: wpr-320895

ABSTRACT

To explore the antagonistic effect of gingerols against the inflammation induced by lectin from Pinellia ternata. In this study, ELISA method was used to determine the effect of different extracts from gingerols on the release of inflammatory factor TNF-α from macrophages induced by lectin from P. ternata. The fluorescence probe was used to determine the effect of gingerols on the changes in ROS of macrophages induced by lectin from P. ternata. The western-blot method was applied to study the effect of gingerols on the increase in expression of cell receptor interacting protein RIP3 in macrophages induced by lectin from P. ternata. The scanning electron microscope (SEM) was used to study the effect of gingerols on morphological changes in macrophages induced by lectin from P. ternata. According to the results, gingerols can significantly inhibit the release of inflammatory factor from macrophages induced by lectin from P. ternata, ROS overproduction and increase in RIP3 expression. SEM results showed that gingerols can inhibit the cytomorphosis and necrocytosis induced by lectin from P. ternata. Fresh ginger's detoxication may be related to gingerols' effects in inhibiing release of inflammatory factor, ROS overproduction and increase in RIP3 expression caused by macrophages induced by lectin from P. ternata, which are mainly inflammatory development.


Subject(s)
Animals , Male , Mice , Catechols , Pharmacology , Cells, Cultured , Drug Antagonism , Fatty Alcohols , Pharmacology , Ginger , Chemistry , Lectins , Toxicity , Macrophages , Metabolism , Mice, Inbred ICR , Pinellia , Chemistry , Toxicity , Reactive Oxygen Species , Metabolism , Receptor-Interacting Protein Serine-Threonine Kinases , Genetics , Metabolism , Tumor Necrosis Factor-alpha , Genetics , Metabolism
5.
Chinese Journal of Applied Physiology ; (6): 193-197, 2014.
Article in Chinese | WPRIM | ID: wpr-236349

ABSTRACT

<p><b>OBJECTIVE</b>To observe the vasodilating effect of adrenomedullin 2 (ADM2) by antagonizing angiotensin 1 (Ang II), and to explore its mechanism.</p><p><b>METHODS</b>Eighteen male, 180-200 g SD rats were randomly divided into 3 groups (n = 6): control group, Ang II (150 ng/(kg x min)) group and Ang II (150 ng/(kg x min)) + ADM2(500 ng/(kg x h)) group. Mini-osmotic pumps filled with peptide were implanted in the back of rats subcutaneously. After two weeks, the blood pressure was measured by the way of carotid intubation. The plasma was collected for the detection of nitric oxide (NO) content and the activity of endothelial nitric oxide synthase (eNOS). The in situ oxidation of fluorescent dye dihydroethidium (DHE) was used for detecting superoxide in rat arteries. The rat isolated arterial rings were made for studying the vasodilating effect of ADM2. Human umbilical vein endothelial cell line EA. hy 926 cells were cultured and their intracellular reactive oxygen species (ROS) were evaluated by probe DCFH-DA.</p><p><b>RESULTS</b>ADM2 dramatically decreased the blood pressure in angiotensin II-induced hypertension rat model, enhanced plasma NO content and the activity of eNOS and reduced superoxide formation in vessel walls. ADM2 also induced relaxation of the vascular rings preconstricted by Ang II in a concentration-dependent and endothelium-dependent manner. In cultured vascular endothelium, ADM2 ameliorated the ROS generation induced by Ang II.</p><p><b>CONCLUSION</b>Adrenomedullin 2 relaxed blood vessels by antagonizing angiotensin II-induced oxidative stress and improving the vascular endothelial function.</p>


Subject(s)
Animals , Humans , Male , Rats , Adrenomedullin , Pharmacology , Angiotensin II , Pharmacology , Antihypertensive Agents , Pharmacology , Blood Pressure , Drug Antagonism , Endothelium, Vascular , Human Umbilical Vein Endothelial Cells , Cell Biology , Nitric Oxide , Blood , Nitric Oxide Synthase Type III , Blood , Oxidative Stress , Rats, Sprague-Dawley , Reactive Oxygen Species , Metabolism , Vasodilation
6.
Infection and Chemotherapy ; : 189-193, 2014.
Article in English | WPRIM | ID: wpr-27053

ABSTRACT

We have investigated the in vitro antimicrobial effects of antibiotic combinations against Orientia tsutsugamushi, the causative agent of scrub typhus. ECV304 cells were infected with the Boryong strain of O. tsutsugamushi and incubated in a medium containing doxycycline (4 microg/mL), azithromycin (0.5 microg/mL), rifampin (4 microg/mL), ciprofloxacin (25 microg/mL), gentamicin (5 microg/mL), cefotaxime (2 microg/mL), or combinations of these agents for 7 days, after which immunofluorescent staining for O. tsutsugamushi was performed. The percentages of infective foci in cultures containing antibiotics compared to those in cultures without antibiotics were 6.2% for doxycycline, 9.6% for azithromycin, 8.8% for rifampin, 96.6% for cefotaxime, 29.7% for doxycycline plus cefotaxime, 23.6% for azithromycin plus cefotaxime, and 41.4% for rifampin plus cefotaxime. These findings show an in vitro antagonism between anti-rickettsial agents and cefotaxime against O. tsutsugamushi. These results suggest that the efficacy of antibiotic combinations involving cefotaxime for the treatment of patients with scrub typhus, particularly those with severe pneumonia, needs to be investigated.


Subject(s)
Humans , Anti-Bacterial Agents , Azithromycin , Cefotaxime , Ciprofloxacin , Doxycycline , Drug Antagonism , Gentamicins , Orientia tsutsugamushi , Pneumonia , Rifampin , Scrub Typhus
7.
Acta méd. peru ; 30(4): 114-119, oct.-dic. 2013. ilus, graf, mapas, tab
Article in Spanish | LILACS, LIPECS | ID: lil-702437

ABSTRACT

Objetivo: Determinar las posibles interacciones farmacológicas de las hojas de Maytenus macrocarpa, con fármacos estimulantes e inhibitorios de la motilidad intestinal. Métodos: Se utilizaron 110 ratones albinos machos, con pesos medios de 25 g, se empleó el método de Arbos y col, se administró carbón activado al 5


vía oral, dosis de 0.1ml/10g, como marcador intestinal. Los grupos experimentales fueron: control (agua destilada 0,3ml), hojas de chuchuhuasi 1 (500mg/kg), hojas de chuchuhuasi 2 (3000mg/kg), atropina (1,5mg/kg), loperamida (5mg/kg), neostigmina (0,4mg/kg), metoclopramida (10mg/kg), hojas de chuchuhuasi 1 con metoclopramida, hojas de chuchuhuasi 1 con loperamida, hojas de chuchuhuasi 2 con metoclopramida y hojas de chuchuhuasi 2 con loperamida. Para la validación estadística se usó la prueba de Wilconxon, ANOVA y Tukey. Resultados: El porcentaje de recorrido intestinal de carbón activado fue de 27,04, 34,15, 31,66, 25,57, 15,89, 43,30, 33,99, 32,40, 27,90, 49,34 y 25,36 respectivamente, el test de ANOVA de dos colas revelo una p=0,0007. El test de Tukey indico p<0.05 versus el control para neostigmina, loperamida y la interacción chuchuhuasi 3000 mg/kg con metoclopramida, en este último, el test de Wilconxon presento un valor p<0,05. Conclusiones: Se observó interacciones farmacológicas de antagonismo sobre la motilidad intestinal, entre chuchuhuasi y Loperamida y sinergismo entre chuchuhuasi y metoclopramida.


Objectives: To determine the possible pharmacological interactions from the leaves of Maytenus macrocarpa with inhibitory and stimulating bowel motility drugs. Methods: We used 110 male albino mice with average weight of 25g, Arbos and others method was applied. Activated charcoal was administered at 5


at dose of 0.1ml/10g, as an intestinal marker. The experimental groups included 0.1 ml/10 g of distilled water, leave extract of M. macrocarpa 1 (500mg/kg), leave extract of M. macrocarpa 2 (3000 mg/kg), 1,5mg/kg of atropine, 5mg/kg of loperamide, 0.4mg/kg of neostigmine, 10mg/kg of metoclopramide, leave extract of M. macrocarpa 1 with metoclopramide, leave extract of M. macrocarpa 1 with loperamide, leave extract of M. macrocarpa 2 with metoclopramide and leave extract of M. macrocarpa 2 with loperamide. The statistical validation was based on Wilconxon, ANOVA and Tukey test. Results: The intestinal charcoal run percentage was 27.04, 34.15, 31.66, 25.57, 15.89, 43.30, 33.99, 32.40, 27.9, 49.34 and 25.36 respectively. The ANOVA test result in p= 0.0007. The Tukey test indicated p <0.05 versus the control group for neostigmine, loperamide, and the interaction between leave extract of M. macrocarpa 2 with metoclopramide, for the last the Wilcoxon test result in p <0.05. Conclusions: It was observed antagonism drug interactions on gastrointestinal motility between leaves extract of M. macrocarpa with loperamide and synergism interactions with metoclopramide.


Subject(s)
Humans , Drug Interactions , Loperamide , Maytenus , Metoclopramide , Gastrointestinal Motility , Plants, Medicinal , Drug Antagonism , Drug Synergism
8.
Journal of Zhejiang University. Medical sciences ; (6): 261-266, 2013.
Article in Chinese | WPRIM | ID: wpr-252635

ABSTRACT

<p><b>OBJECTIVE</b>To evaluate the effects of aminoguanidine on methylglyoxal-mediated oxygen-glucose deprivation (OGD) injury in the cultured human brain microvascular endothelial cells (HBMEC).</p><p><b>METHODS</b>Cultured HBMEC cells were pretreated with methylglyoxal before oxygen-glucose deprivation injury. Cell vitality was determined by MTT method, cell mortality was assessed by LDH release method, cell apoptosis was examined by Annexin V/PI formation method, and the advanced glycation end products (AGEs) were detected by Western-blot.</p><p><b>RESULTS</b>Methylglyoxal induced HBMEC injury in a dose-dependent manner. At 2 mmol/L of methylglyoxal, the cell viability was 56.1% when methylglyoxal-pretreated cells exposed to oxygen-glucose deprivation, the cell inhibition rate was 90.0%. Aminoguanidine (1 mmol/L) inhibited methylglyoxal and OGD induced LDH release and Annexin V/PI formation. Furthermore, aminoguanidine (1 mmol/L) also decreased advanced glycation end products (AGEs) formation induced by methylglyoxal and oxygen-glucose deprivation.</p><p><b>CONCLUSION</b>Aminoguanidine protected methylglyoxal mediated-oxygen-glucose deprivation injury in the cultured HBMEC, which may be associated with anti-glycation activity.</p>


Subject(s)
Humans , Apoptosis , Cell Hypoxia , Cell Survival , Cells, Cultured , Drug Antagonism , Endothelial Cells , Metabolism , Pathology , Endothelium, Vascular , Cell Biology , Glycation End Products, Advanced , Metabolism , Guanidines , Pharmacology , Pyruvaldehyde , Pharmacology
9.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 1665-1667, 2013.
Article in Chinese | WPRIM | ID: wpr-231624

ABSTRACT

<p><b>OBJECTIVE</b>To quantitatively evaluate mutual relations of 4 component drugs in anti-HIV action.</p><p><b>METHODS</b>The effect of TCM four components on cell growth was detected using MTT assay. The antiviral effects of 4 components were observed at the maximal nonvenomous dose. The combination index (CI) value of combined two or four components were calculated using median-effect principle. The mutual relations of two or four components for antiviral actions were assessed using CI.</p><p><b>RESULTS</b>Synergism was dominant in combination of A and B, and the effect was dose-dependent. Antagonism was dominant in combination of C and D, and the effect was dose-dependent. But the combination of A, B, C, and D was synergistic when the inhibition rate was over 10%.</p><p><b>CONCLUSION</b>Median-effect principle can be used to quantitatively assess the anti-HIV effect of four components.</p>


Subject(s)
Humans , Antiviral Agents , Pharmacology , Cell Line , Dose-Response Relationship, Drug , Drug Antagonism , Drug Synergism , HIV-1
10.
Acta Academiae Medicinae Sinicae ; (6): 530-534, 2013.
Article in Chinese | WPRIM | ID: wpr-285965

ABSTRACT

<p><b>OBJECTIVE</b>To study the inhibitory effect of the dual usage of BEZ235 and U0126, the inhibitor of phosphatidyl inositol-3-kinase/protein kinase B pathway and extracellular regulated proteinkinase/mitogen-activated protein kinase pathway, respectively, on cell proliferation.</p><p><b>METHODS</b>Phosphatase and tensin homolog knockout mouse embryonic fibroblast (PTEN-/-MEF) cell lines were used as the cellular model for malignant tumors. BEZ235, the dual inhibitor of phosphatidyl inositol-3-kinase and mammalian target of rapamycin, and U0126, the inhibitor of mitogen-activated protein kinase were used to treat the cells individually and in a combination manner. The inhibitory effects to cell proliferation were monitored by MTT.</p><p><b>RESULTS</b>Both BEZ235 and U0126 suppressed PTEN knockout cell proliferation, and their half inhibitory concentrations were 6.257 nmol/L and 22.85 μmol/L, respectively. However, the combination treatment of the two drugs showed antagonistic rather than synergistic effect on cell proliferation.</p><p><b>CONCLUSION</b>BEZ235 and U0126 are not suitable for a combined target therapy regimen.</p>


Subject(s)
Animals , Mice , Butadienes , Pharmacology , Cell Line , Cell Proliferation , Drug Antagonism , Fibroblasts , Imidazoles , Pharmacology , Mice, Knockout , Nitriles , Pharmacology , Phosphatidylinositol 3-Kinase , Pharmacology , Quinolines , Pharmacology
11.
Chinese Journal of Integrated Traditional and Western Medicine ; (12): 686-690, 2013.
Article in Chinese | WPRIM | ID: wpr-287487

ABSTRACT

<p><b>OBJECTIVE</b>To study the toxicity changes of different proportions of Radix Adenophora, Radix Glehniae combined with Veratrum nigrum L., thus providing acute toxicity data and investigating whether decoction factors were correlated with toxicity.</p><p><b>METHODS</b>The uniform design method was used by two factors and seven levels to investigate the toxicity changes in different proportions of Radix Adenophora, Radix Glehniae combined with Veratrum nigrum L. The decoction factors were also investigated.</p><p><b>RESULTS</b>The compatibility toxicity was affected mainly by Veratrum nigrum L. and the toxicity increased along with increased doses of Veratrum nigrum L. The toxicity of co-decoction was higher than mixed decoction in the same dosage of Radix Glehniae and Veratrum nigrum L. The promotion of the dissolution of the toxic component of Veratrum nigrum L. in co-decoction may be the cause of the higher toxicity.</p><p><b>CONCLUSION</b>Radix Adenophora and Radix Glehniae combined with Veratrum nigrum L. resulted in higher toxicity, which indicated that the incompatibility between Radix Adenophora, Radix Glehniae, and Veratrum nigrum L. In clinic practice, a prescription contained these drugs should be avoided.</p>


Subject(s)
Animals , Female , Male , Mice , Drug Antagonism , Drug Incompatibility , Drugs, Chinese Herbal , Toxicity
12.
Chinese Journal of Hepatology ; (12): 845-849, 2013.
Article in Chinese | WPRIM | ID: wpr-277985

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the anti-cancer efficacy and mechanism of sorafenib and 5-fluorouracil (5-FU) therapy in vitro using the HCC cell line MHCCLM3.</p><p><b>METHODS</b>The effects of sorafenib and 5-FU, alone or in combination, on the proliferation of MHCCLM3 cells were evaluated by cell viability assays. Combined-effects analyses were conducted according to the median-effect principle established by Chou and Talalay. Effects on cell cycle distributions were tested by flow cytometry and expression of proteins related to the RAF/MEK/ERK and STAT3 signaling pathways and cyclinD1 were tested by western blotting.</p><p><b>RESULTS</b>Sorafenib and 5-FU alone or in combination displayed significant efficacy in inhibiting proliferation of the MHCCLM3 cells, with the following inhibition rates: sorafenib: 46.16% +/- 2.52%, 5-FU: 28.67% +/- 6.16%, and sorafenib + 5-FU: 22.59% +/- 6.89%. The sorafenib + 5-FU combination did not provide better results than treatment with either drug alone. The combination index values of the sorafenib and 5-FU treatments were mainly greater than 1, indicating that the two agents induced antagonistic, instead of synergistic, effects on the MHCCLM3 cells. In addition, the MHCCLM3 cells were less sensitive to 5-FU when administrated in combination with sorafenib, as evidenced by the half inhibitory concentration (IC50) significantly increasing from (102.86 +/- 27.84) mg/L to (178.61 +/- 20.73) mg/L (P = 0.003). Sorafenib alone induced G1 phase arrest (increasing from 44.73% +/- 1.63% to 65.80% +/- 0.56%; P less than 0.001) and significantly decreased the proportion of cells in S phase (decreasing from 46.63% +/- 0.65% to 22.83% +/- 1.75%; P less than 0.01), as well as down-regulated cyclinD1 expression (0.57 +/- 0.03-fold change vs. untreated control group; P less than 0.01). 5-FU alone up-regulated cyclinD1 expression (1.45 +/- 0.12-fold change vs. untreated control group; P less than 0.01). Moreover, sorafenib alone significantly inhibited the RAF/MEK/ERK and STAT3 pathways, with the fold-changes of p-C-RAF, p-ERK1/2 and p-STAT3 being 0.56 +/- 0.05, 0.54 +/- 0.02 and 0.36 +/- 0.02, respectively (all P less than 0.01); 5-FU alone produced no significant effects on these pathways.</p><p><b>CONCLUSION</b>Administered alone, both sorafenib and 5-FU exert anti-tumoral activity on in vitro cultured HCC cells. The sorafenib + 5-FU combination treatment produces antagonistic, rather than synergistic, effects. Sorafenib-inhibited RAF/MEK/ERK and STAT3 signaling and cyclinD1 expression may have induced the observed G1phase arrest and S phase reduction, thereby reducing the cells' sensitivity to 5-FU.</p>


Subject(s)
Humans , Cell Line, Tumor , Cell Proliferation , Cyclin D1 , Metabolism , Drug Antagonism , Fluorouracil , Pharmacology , Niacinamide , Pharmacology , Phenylurea Compounds , Pharmacology , STAT3 Transcription Factor , Metabolism , Signal Transduction
13.
Rev. colomb. biotecnol ; 13(2): 176-185, dic 1, 2011. graf, tab
Article in Spanish | LILACS | ID: lil-645179

ABSTRACT

Trichoderma sp es un hongo frecuentemente usado en actividades agrícolas, pues actúa como antagonista de diversas especies de hongos fitopatógenos. En este estudio se realizó el aislamiento de cuatro cepas de Trichoderma sp nativas del noreste de México, las cuales fueron identificadas a nivel molecular mediante la secuenciación del ITS 1. Además se evaluó su capacidad antagonista en contra los hongos fitopatógenos Macrophomina phaseolina y Fusarium oxysporum, que afectan severamente cultivos de sorgo, maíz y fríjol en el noreste de México. La identificación se realizó de acuerdo al grado de concordancia con secuencias reportadas y corresponden a las especies T. hammatum (HK701); T. koningiopsis (HK702); T. asperellum (HK703) y Trichoderma sp (HK704). Por otra parte, las pruebas de antagonismo muestran que los aislados HK701, HK703 y HK704 inhiben por competencia el crecimiento de M. phaseolina y F. oxysporum, mientras que HK702 tiene la capacidad para hiperparasitar dichos fitopatógenos. Finalmente, se evaluó la promoción de crecimiento de T. asperellum HK703, en maíz (Pionner 30P49®), usando para ello concentraciones de tratamiento de 1x10e2 hasta 1x10e6 esp/mL. En estos ensayos se midió la producción de biomasa. Los resultados muestran que en concentraciones intermedias se tiene el mayor incremento en altura de plantas y mayor producción de peso seco en follaje y raíz. Entre los parámetros antes mencionados existen diferencias significativas.


Trichoderma sp is a fungus often used in agricultural activities, because it acts as an antagonist of several species of plant pathogenic fungi. In this study four strains of Trichoderma sp was isolated from the northeastern Mexico, which were identified by sequencing the ITS 1. We also evaluated its ability antagonistic against phytopathogenic fungi Macrophomina phaseolina and Fusarium oxysporum this fungi are reported affecting severely maize, sorghum and beans crops in northeastern Mexico. The identification was made according to the degree of consistency with reported sequences and the data show that the isolates belong to the species T. hammatum (HK701), T. koningiopsis (HK702), T. asperellum (HK703) and Trichoderma sp (HK704). Antagonism tests showed that the isolated, HK701, HK703 and HK704 inhibited the growth by competition to M phaseolina and F. oxysporum, while the HK702 has the ability to hyperparasites these pathogens. Finally was evaluated in maize (Pioneer 30P49®) We measured the dry weight and biomass production. The results show that at intermediate concentrations have the greatest increase in plant height and dry height of root and foliage.


Subject(s)
Drug Antagonism , Drug Incompatibility
14.
Journal of Zhejiang University. Medical sciences ; (6): 667-672, 2011.
Article in Chinese | WPRIM | ID: wpr-247195

ABSTRACT

<p><b>OBJECTIVE</b>To determine the effect of proton pump inhibitor (PPI) on in-stent restenosis (ISR) in patients receiving clopidogrel therapy.</p><p><b>METHODS</b>Total 439 patients underwent percutaneous coronary intervention (PCI) were enrolled in the study,including 250 post-PCI patients discharged on clopidogrel alone and 189 patients discharged on clopidogrel with PPI. The in-stent restenosis (ISR) ratio of the patients in these two groups were observed.</p><p><b>RESULTS</b>During a mean follow-up period of (13 ± 5.9) months, the post-PCI patients discharged on concomitant clopidogrel-PPI therapy had higher risk of ISR than those discharged on clopidogrel alone (19.6% Compared with 8%, P<0.001).</p><p><b>CONCLUSION</b>Concomitant use of clopidogrel and PPI after hospital discharge would increase the risk of ISR for post-PCI patients.</p>


Subject(s)
Humans , Angioplasty, Balloon, Coronary , Coronary Restenosis , Drug Antagonism , Drug Therapy, Combination , Follow-Up Studies , Platelet Aggregation Inhibitors , Therapeutic Uses , Proton Pump Inhibitors , Therapeutic Uses , Retrospective Studies , Risk , Stents , Ticlopidine , Therapeutic Uses
15.
Chinese journal of integrative medicine ; (12): 126-133, 2011.
Article in English | WPRIM | ID: wpr-308685

ABSTRACT

<p><b>OBJECTIVE</b>To study the effect of anticolchicine cytotoxicity of Dan Gua-Fang, a Chinesea Chinese), a Chinese herbal compound prescription on endothelial cells of vein (ECV304) cultivated in mediums of different glucose concentrations as well as the proliferation of those cells in the same conditions, in order to reveal the value of Dan Gua-Fang in preventing and treating endothelial damage caused by hyperglycemia in diabetes mellitus.</p><p><b>METHODS</b>The research was designed as three stages. The growing state and morphological changes were observed when ECV304 were cultivated in the culture mediums, which have different glucose concentrations with or without Dan Gua-Fang and at the same time with or without colchicine.</p><p><b>RESULTS</b>(1) Dan Gua-Fang at all concentrations reduced the floating cell population of ECV304 cultivated in hyperglycemia mediums. (2) Dan Gua-Fang at all concentrations and hyperglycemia both had a function of promoting "pseudopod-like" structure formation in cultivated ECV304, but the function was not superimposed in mediums containing both hyperglycemia and Dan Gua-Fang. (3) Colchicine reduced and even vanished the "pseudopod-like" structure of the endotheliocyte apparently cultivated in mediums of hyperglycemia or with Dan Gua-Fang. The "pseudopod-like" structure of the endotheliocyte emerged quickly in Dan Gua-Fang groups after colchicine was removed, but it was not the case in hyperglycemia only without Dan Gua-Fang groups. (4) Dan Gua-Fang reduced the mortality of cells cultivated in mediums containing colchicine. The cell revived to its normal state fast after colchicine was removed.</p><p><b>CONCLUSION</b>Dan Gua-Fang has the functions of promoting the formation of cytoskeleton and fighting against colchicine cytotoxicity.</p>


Subject(s)
Humans , Cell Culture Techniques , Cell Line , Cell Shape , Colchicine , Culture Media , Pharmacology , Cytoprotection , Cytotoxins , Drug Antagonism , Drug Combinations , Drug Evaluation, Preclinical , Drug Synergism , Drugs, Chinese Herbal , Pharmacology , Endothelial Cells , Physiology , Glucose , Pharmacology , Umbilical Veins , Cell Biology , Up-Regulation
16.
Journal of Southern Medical University ; (12): 578-581, 2011.
Article in Chinese | WPRIM | ID: wpr-307881

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of fluvastatin on lysophosphatidylcholine (LPC)-induced ventricular arrhythmias and its mechanism.</p><p><b>METHODS</b>Twenty male SD rats were randomly allocated into two equal groups, namely LPC treatment group and fluvastatin pretreatment group. Langendorff apparatus was used for cardiac perfusion ex vivo with 5 µmol/L LPC for 5 min followed by washing for 30 min in LPC treatment group, and in fluvastatin pretreatment group, a 30-min perfusion with 10 µmol/L fluvastatin was administered before LPC perfusion. The LPC-induced nonselective cation current (I(NSC)) in the ventricular myocytes was recorded using the whole-cell voltage-clamp method.</p><p><b>RESULTS</b>Fluvastatin significantly inhibited LPC-induced ventricular tachyarrhythmia/fibrillation and I(NSC). The small G-protein Rho inhibitor (C3) and Rho-kinase inhibitor (Y-27632) in the pipette solution also suppressed LPC-induced I(NSC).</p><p><b>CONCLUSION</b>Fluvastatin offers cardiac protection against LPC by inhibiting LPC-induced I(NSC). LPC induces fatal arrhythmia via a Rho/Rho-kinase-mediated pathway.</p>


Subject(s)
Animals , Male , Rats , Arrhythmias, Cardiac , Metabolism , Drug Antagonism , Fatty Acids, Monounsaturated , Pharmacology , Indoles , Pharmacology , Ion Channels , Lysophosphatidylcholines , Myocytes, Cardiac , Metabolism , Rats, Sprague-Dawley , rho-Associated Kinases , Metabolism
17.
Journal of Zhejiang University. Medical sciences ; (6): 71-77, 2011.
Article in Chinese | WPRIM | ID: wpr-319830

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effect of AT₁ receptor on the changes of tyrosine hydroxylase-immunoreactivity (TH-IR) in rostral ventrolateral medulla (RVLM) induced by brain cholinergic stimuli in rats.</p><p><b>METHODS</b>Male SD rats were randomly divided into 4 groups: NS + CBC group, Los + CBC group, Los + NS group and NS + NS group. AT₁ was blocked by pretreatment of 20 μg losartan in Los + CBC and Los + NS groups; intracerebroventricular injection of 0.5 μg carbachol was used for cholinergic stimuli in NS + CBC and Los + CBC groups; normal saline (NS) was used for control. The output amount of natrium in kidney, glomerular filtration rate (GFR) and renal plasma flow (PRF) were observed. The changes of TH-IR in the RVLM were observed by immunohistochemistry.</p><p><b>RESULT</b>In NS + CBC group carbachol induced potent natriuresis, after pretreatment of losartan the natriuretic effect was partially inhibited in Los + CBC group. Both the number and optical density of TH-IR positive neurons in NS + CBC group were markedly increased than those in NS + NS group (P < 0.05); while those in Los + CBC group were significantly lower than those in NS+CBC group (P < 0.05). Intracerebroventricular injection of carbachol and losartan had no effect on GFR and RPF(P > 0.05).</p><p><b>CONCLUSION</b>The results suggest that cholinergic stimuli can induce potent natriuresis and increase the activity of adrenergic neurons in the RVLM; the above effects can be down regulated by blockade of brain AT₁ receptor.</p>


Subject(s)
Animals , Male , Rats , Carbachol , Pharmacology , Drug Antagonism , Glomerular Filtration Rate , Losartan , Pharmacology , Medulla Oblongata , Metabolism , Natriuresis , Random Allocation , Rats, Sprague-Dawley , Receptor, Angiotensin, Type 1 , Physiology , Tyrosine 3-Monooxygenase , Metabolism
18.
Chinese journal of integrative medicine ; (12): 41-49, 2010.
Article in English | WPRIM | ID: wpr-344950

ABSTRACT

<p><b>OBJECTIVE</b>Changes of the internal and external cellular environments can induce calcium homeostasis disorder and unfolded protein aggregation in the endoplasmic reticulum (ER). This ER function disorder is called endoplasmic reticulum stress (ERS). Severe long-term ERS can trigger the ER apoptosis signaling pathway, resulting in cell apoptosis and organism injury. Recent researches revealed that ERS-induced cell death was involved in the neurocyte retrogradation in the progress of neuron degenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease and so on. Therefore, the protection effect of the traditional Chinese drug-Tiantai No. 1 (1) on the ERS injury of AD was investigated at the molecular gene level in this study with a view to explore the gene pharmacodynamic actions and mechanisms of this drug.</p><p><b>METHODS</b>Primarily cultured marrow mesenchymal stem cells (MSCs) of rats were treated by tunicamycin (TM) in order to induce ERS. RT-PCR, fluorescence immunocytochemistry and Western blot techniques were used to determine the mRNA and protein expression levels of the protective stress protein-ER molecular chaperones GRP78 and GRP94 (which would assist cells to resist cellular stress injury), and to determine the mRNA and protein expression levels of apoptosis promoting molecule Caspase-12 on the membrane of the ER, respectively.</p><p><b>RESULTS</b>Protein expression levels of GRP78 and GRP94 were significantly increased in the TM-induced MSCs, and the mRNA level of Caspase-12 was also remarkably increased in the TM-induced MSCs (P<0.05). All these proved that the ERS model was successfully established by TM in MSC. Meanwhile, the mRNA and protein levels of GRP78 and GRP94 were all significantly increased compared with the model group (P<0.05 or P<0.01) after MSCs were treated with Tiantai No.1 while the mRNA and protein expression levels of Caspase-12 were significantly decreased compared with the model group (P<0.05 or P<0.01). This effect showed a dose dependent manner.</p><p><b>CONCLUSION</b>Tiantai No.1 might attenuate the cell apoptosis induced by ERS injury, and thus protect the neurons against AD.</p>


Subject(s)
Animals , Male , Rabbits , Rats , Anti-Bacterial Agents , Pharmacology , Cells, Cultured , Drug Antagonism , Drugs, Chinese Herbal , Pharmacology , Endoplasmic Reticulum , Metabolism , Gene Expression Regulation , Heat-Shock Proteins , Genetics , Metabolism , Membrane Glycoproteins , Genetics , Metabolism , Mesenchymal Stem Cells , Metabolism , RNA , Rats, Sprague-Dawley , Stress, Physiological , Genetics , Tunicamycin , Pharmacology
19.
Rev. cuba. farm ; 43(2)mayo-ago. 2009. tab
Article in Spanish | LILACS | ID: lil-531356

ABSTRACT

El presente trabajo tuvo como objetivo, evaluar la eficacia clínica del tratamiento antimicrobiano combinado mediante pruebas de sinergismo in vitro y determinar la eficacia del procedimiento empleado para orientar la aplicación de estas formas de tratamiento en el paciente con sepsis por bacterias con resistencia variada. Se evaluó el tratamiento aplicado a 163 recién nacidos con sepsis corroborada por hemocultivo positivo en el Hospital Ginecobstétrico Universitario "América Arias", durante el periodo de enero de 1993 a diciembre de 2000, por el método tablero de damas (checkerboard) en placas de microtitulación. Las combinaciones de fßrmacos sinérgicas in vitro presentaron una alta probabilidad de eficacia clínica, independiente del patrón de susceptibilidad del microorganismo aun frente a cepas resistentes a los 2 antimicrobianos utilizados en el tratamiento. Todos los resultados antagónicos in vitro se correspondieron con un fallo clínico terapéutico. El procedimiento utilizado puede constituir una valiosa herramienta para orientar la terapéutica en pacientes con sepsis por microorganismos resistentes.


The aim of present paper was to evaluate clinical effectiveness of combined antimicrobial treatment by means of in vitro synergism tests and to determine effectiveness of used procedure to direct applications of these treatment strategies in patient presenting with sepsis from varied resistance bacteria. Treatment applied was assessed in 163 newborn patients presenting with sepsis from positive hemoculture in "America Arias" University Gynecology-Obstetrics Hospital from January 1993 to December 2000, by checkerboard method in microtritate plates. In vitro synergic drug combinations showed a high probability of clinical effectiveness, independently of susceptibility pattern of microorganism event versus resistant strains to both antimicrobials used in treatment. All in vitro antagonistic results correspond both with a therapeutic clinical failure. Procedure used may be a valuable tool to direct therapeutics in patients presenting with sepsis from resistant microorganisms.


Subject(s)
Humans , Infant, Newborn , Drug Antagonism , Drug Synergism , In Vitro Techniques , Treatment Outcome , Combined Modality Therapy/methods , Case Reports
20.
Acta Academiae Medicinae Sinicae ; (6): 598-602, 2009.
Article in Chinese | WPRIM | ID: wpr-301643

ABSTRACT

<p><b>OBJECTIVE</b>To investigate the effects of emodin on expression of cytokines induced by lipopolysaccharide (LPS) in cultured human corneal fibroblasts in vitro.</p><p><b>METHODS</b>Primary human corneal fibroblasts of passages 4 were used in this research. Cells were treated with 10 microg/L LPS for 1, 2, 4, or 8 hours, which were pretreated with or without emodin for 30 minutes before LPS challenge. The degeneration of inhibitor of kappaB-alpha (I kappaB-alpha) and the effect of emodin on it were analyzed by Western blot analysis with a specific antibody. The cellular abundance of the mRNA of interleukin (IL)-6 and IL-8 from corneal fibroblasts under different conditions was determined by reverse transcriptase polymerase chain reaction (RT-PCR).</p><p><b>RESULTS</b>Compared with cells without LPS treatment, I kappaB-alpha level significantly decreased in every time point after LPS challenge (P < 0.01). Emodin inhibited the LPS-induced degeneration of I kappaB-alpha by corneal fibroblasts in a dose-dependent manner (P < 0.05). Compared with cells without LPS treatment, the expressions of IL-6 and IL-8 mRNA significantly increased in every time point after LPS challenge (P < 0.01). At the same time, the expressions of the mRNA of IL-6 and IL-8 induced by LPS in corneal fibroblasts were also inhibited by emodin in a dose-dependent manner (P < 0.05).</p><p><b>CONCLUSION</b>Emodin can inhibit the expressions of IL-6 and IL-8 mRNA induced by LPS in corneal fibroblasts, which maybe via inhibiting the degeneration of I kappaB-alpha and suppressing the activation of nuclear factor-kappaB.</p>


Subject(s)
Humans , Cells, Cultured , Cornea , Cell Biology , Metabolism , Drug Antagonism , Emodin , Pharmacology , Fibroblasts , Metabolism , Interleukin-6 , Genetics , Metabolism , Interleukin-8 , Genetics , Metabolism , Lipopolysaccharides , Toxicity , NF-kappa B , Metabolism , RNA, Messenger , Genetics
SELECTION OF CITATIONS
SEARCH DETAIL